Managing Immunogenicity Risk in Biopharmaceuticals 2012
08 Mar 2012
Webinar
Key Topics
Risk factors associated with immunogenicity
Self versus non-self
How to use immunogenicity results from pre-clinical studies
Regulatory expectations on immunogenicity testing
Phase specific sampling plan
Minimizing immunogenicity risk
Case study and commercialization strategy
Who should Attend
Toxicologists, Pharmacologists, Project Managers, Clinicians, Consultants and Regulatory personnel from companies that are developing biopharmaceuticals that are NOT being used as vaccines.
Past Events
Managing Immunogenicity Risk in Biopharmaceuticals 2012 - 08 Mar 2012, Webinar (26427)
Managing Immunogenicity Risk in Biopharmaceuticals 2026
Important
Please, check "Managing Immunogenicity Risk in Biopharmaceuticals" official website for possible changes, before making any traveling arrangements
